Global mRNA Vaccines for Infectious Diseases Market Research Report 2025(Status and Outlook)
Description
Report Overview
mRNA vaccines for infectious diseases are a type of vaccine that uses messenger RNA to instruct cells in the body to produce a protein that triggers an immune response. This immune response helps the body recognize and fight off the infectious agent, providing protection against specific diseases. mRNA vaccines have gained significant attention and popularity in recent years due to their ability to be developed and manufactured quickly, as demonstrated by the rapid development of mRNA vaccines for COVID-19. These vaccines are considered a groundbreaking technology in the field of immunization, offering potential advantages such as scalability, flexibility, and the absence of live pathogens, making them a promising tool in the fight against infectious diseases.
The market for mRNA vaccines for infectious diseases is experiencing a significant upward trend, driven by several factors. One key driver is the growing global demand for effective and innovative vaccines to combat infectious diseases, particularly in the wake of the COVID-19 pandemic. The success of mRNA vaccines in providing a rapid response to the pandemic has highlighted their potential and paved the way for further research and development in this area. Additionally, advancements in mRNA technology, increased funding for vaccine research, and collaborations between pharmaceutical companies and research institutions are fueling the expansion of the market. As a result, more companies are investing in the development of mRNA vaccines for a wide range of infectious diseases, leading to a competitive and dynamic market landscape.
At the same time, market drivers such as the increasing prevalence of infectious diseases, the need for more effective and targeted vaccines, and the growing awareness of the importance of vaccination in disease prevention are further propelling the growth of the mRNA vaccine market. Governments and healthcare organizations are also recognizing the potential of mRNA vaccines in addressing public health challenges and are actively supporting research and deployment efforts. Moreover, the ongoing technological advancements in mRNA vaccine production, distribution, and storage are overcoming previous limitations and expanding the market's reach. Overall, the market for mRNA vaccines for infectious diseases is poised for continued growth and innovation, driven by a combination of scientific progress, market demand, and industry collaboration.
The global mRNA Vaccines for Infectious Diseases market size was estimated at USD 31826.25 million in 2024 and is projected to reach USD 38777.20 million by 2033, exhibiting a CAGR of 2.50% during the forecast period.
This report provides a deep insight into the global mRNA Vaccines for Infectious Diseases market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter's five forces analysis, value chain analysis, PEST analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global mRNA Vaccines for Infectious Diseases Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the mRNA Vaccines for Infectious Diseases market in any manner.
Global mRNA Vaccines for Infectious Diseases Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Moderna Therapeutics
CureVac
Translate Bio
BioNTech
Sangamo Therapeutics
Argos Therapeutics
In-Cell-Art
eTheRNA
Ethris
Tiba Biotechnology
Market Segmentation (by Type)
Infectious Disease Vaccines
Cancer Vaccines
Market Segmentation (by Application)
Infectious Disease
Cancer
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the mRNA Vaccines for Infectious Diseases Market
Overview of the regional outlook of the mRNA Vaccines for Infectious Diseases Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the mRNA Vaccines for Infectious Diseases Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region from the consumer side and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of mRNA Vaccines for Infectious Diseases, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region during the forecast period.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment during the forecast period.
Chapter 13 is the main points and conclusions of the report.
mRNA vaccines for infectious diseases are a type of vaccine that uses messenger RNA to instruct cells in the body to produce a protein that triggers an immune response. This immune response helps the body recognize and fight off the infectious agent, providing protection against specific diseases. mRNA vaccines have gained significant attention and popularity in recent years due to their ability to be developed and manufactured quickly, as demonstrated by the rapid development of mRNA vaccines for COVID-19. These vaccines are considered a groundbreaking technology in the field of immunization, offering potential advantages such as scalability, flexibility, and the absence of live pathogens, making them a promising tool in the fight against infectious diseases.
The market for mRNA vaccines for infectious diseases is experiencing a significant upward trend, driven by several factors. One key driver is the growing global demand for effective and innovative vaccines to combat infectious diseases, particularly in the wake of the COVID-19 pandemic. The success of mRNA vaccines in providing a rapid response to the pandemic has highlighted their potential and paved the way for further research and development in this area. Additionally, advancements in mRNA technology, increased funding for vaccine research, and collaborations between pharmaceutical companies and research institutions are fueling the expansion of the market. As a result, more companies are investing in the development of mRNA vaccines for a wide range of infectious diseases, leading to a competitive and dynamic market landscape.
At the same time, market drivers such as the increasing prevalence of infectious diseases, the need for more effective and targeted vaccines, and the growing awareness of the importance of vaccination in disease prevention are further propelling the growth of the mRNA vaccine market. Governments and healthcare organizations are also recognizing the potential of mRNA vaccines in addressing public health challenges and are actively supporting research and deployment efforts. Moreover, the ongoing technological advancements in mRNA vaccine production, distribution, and storage are overcoming previous limitations and expanding the market's reach. Overall, the market for mRNA vaccines for infectious diseases is poised for continued growth and innovation, driven by a combination of scientific progress, market demand, and industry collaboration.
The global mRNA Vaccines for Infectious Diseases market size was estimated at USD 31826.25 million in 2024 and is projected to reach USD 38777.20 million by 2033, exhibiting a CAGR of 2.50% during the forecast period.
This report provides a deep insight into the global mRNA Vaccines for Infectious Diseases market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter's five forces analysis, value chain analysis, PEST analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global mRNA Vaccines for Infectious Diseases Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the mRNA Vaccines for Infectious Diseases market in any manner.
Global mRNA Vaccines for Infectious Diseases Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Moderna Therapeutics
CureVac
Translate Bio
BioNTech
Sangamo Therapeutics
Argos Therapeutics
In-Cell-Art
eTheRNA
Ethris
Tiba Biotechnology
Market Segmentation (by Type)
Infectious Disease Vaccines
Cancer Vaccines
Market Segmentation (by Application)
Infectious Disease
Cancer
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the mRNA Vaccines for Infectious Diseases Market
Overview of the regional outlook of the mRNA Vaccines for Infectious Diseases Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the mRNA Vaccines for Infectious Diseases Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region from the consumer side and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of mRNA Vaccines for Infectious Diseases, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region during the forecast period.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment during the forecast period.
Chapter 13 is the main points and conclusions of the report.
Table of Contents
168 Pages
- 1 Research Methodology and Statistical Scope
- 1.1 Market Definition and Statistical Scope of mRNA Vaccines for Infectious Diseases
- 1.2 Key Market Segments
- 1.2.1 mRNA Vaccines for Infectious Diseases Segment by Type
- 1.2.2 mRNA Vaccines for Infectious Diseases Segment by Application
- 1.3 Methodology & Sources of Information
- 1.3.1 Research Methodology
- 1.3.2 Research Process
- 1.3.3 Market Breakdown and Data Triangulation
- 1.3.4 Base Year
- 1.3.5 Report Assumptions & Caveats
- 2 mRNA Vaccines for Infectious Diseases Market Overview
- 2.1 Global Market Overview
- 2.1.1 Global mRNA Vaccines for Infectious Diseases Market Size (M USD) Estimates and Forecasts (2020-2033)
- 2.1.2 Global mRNA Vaccines for Infectious Diseases Sales Estimates and Forecasts (2020-2033)
- 2.2 Market Segment Executive Summary
- 2.3 Global Market Size by Region
- 3 mRNA Vaccines for Infectious Diseases Market Competitive Landscape
- 3.1 Company Assessment Quadrant
- 3.2 Global mRNA Vaccines for Infectious Diseases Product Life Cycle
- 3.3 Global mRNA Vaccines for Infectious Diseases Sales by Manufacturers (2020-2025)
- 3.4 Global mRNA Vaccines for Infectious Diseases Revenue Market Share by Manufacturers (2020-2025)
- 3.5 mRNA Vaccines for Infectious Diseases Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 3.6 Global mRNA Vaccines for Infectious Diseases Average Price by Manufacturers (2020-2025)
- 3.7 Manufacturers mRNA Vaccines for Infectious Diseases Sales Sites, Area Served, Product Type
- 3.8 mRNA Vaccines for Infectious Diseases Market Competitive Situation and Trends
- 3.8.1 mRNA Vaccines for Infectious Diseases Market Concentration Rate
- 3.8.2 Global 5 and 10 Largest mRNA Vaccines for Infectious Diseases Players Market Share by Revenue
- 3.8.3 Mergers & Acquisitions, Expansion
- 4 mRNA Vaccines for Infectious Diseases Industry Chain Analysis
- 4.1 mRNA Vaccines for Infectious Diseases Industry Chain Analysis
- 4.2 Market Overview of Key Raw Materials
- 4.3 Midstream Market Analysis
- 4.4 Downstream Customer Analysis
- 5 The Development and Dynamics of mRNA Vaccines for Infectious Diseases Market
- 5.1 Key Development Trends
- 5.2 Driving Factors
- 5.3 Market Challenges
- 5.4 Market Restraints
- 5.5 Industry News
- 5.5.1 New Product Developments
- 5.5.2 Mergers & Acquisitions
- 5.5.3 Expansions
- 5.5.4 Collaboration/Supply Contracts
- 5.6 PEST Analysis
- 5.6.1 Industry Policies Analysis
- 5.6.2 Economic Environment Analysis
- 5.6.3 Social Environment Analysis
- 5.6.4 Technological Environment Analysis
- 5.7 Global mRNA Vaccines for Infectious Diseases Market Porter's Five Forces Analysis
- 5.7.1 Global Trade Frictions
- 5.7.2 Global Trade Frictions and Their Impacts to mRNA Vaccines for Infectious Diseases Market
- 5.8 ESG Ratings of Leading Companies
- 6 mRNA Vaccines for Infectious Diseases Market Segmentation by Type
- 6.1 Evaluation Matrix of Segment Market Development Potential (Type)
- 6.2 Global mRNA Vaccines for Infectious Diseases Sales Market Share by Type (2020-2025)
- 6.3 Global mRNA Vaccines for Infectious Diseases Market Size Market Share by Type (2020-2025)
- 6.4 Global mRNA Vaccines for Infectious Diseases Price by Type (2020-2025)
- 7 mRNA Vaccines for Infectious Diseases Market Segmentation by Application
- 7.1 Evaluation Matrix of Segment Market Development Potential (Application)
- 7.2 Global mRNA Vaccines for Infectious Diseases Market Sales by Application (2020-2025)
- 7.3 Global mRNA Vaccines for Infectious Diseases Market Size (M USD) by Application (2020-2025)
- 7.4 Global mRNA Vaccines for Infectious Diseases Sales Growth Rate by Application (2020-2025)
- 8 mRNA Vaccines for Infectious Diseases Market Sales by Region
- 8.1 Global mRNA Vaccines for Infectious Diseases Sales by Region
- 8.1.1 Global mRNA Vaccines for Infectious Diseases Sales by Region
- 8.1.2 Global mRNA Vaccines for Infectious Diseases Sales Market Share by Region
- 8.2 Global mRNA Vaccines for Infectious Diseases Market Size by Region
- 8.2.1 Global mRNA Vaccines for Infectious Diseases Market Size by Region
- 8.2.2 Global mRNA Vaccines for Infectious Diseases Market Size Market Share by Region
- 8.3 North America
- 8.3.1 North America mRNA Vaccines for Infectious Diseases Sales by Country
- 8.3.2 North America mRNA Vaccines for Infectious Diseases Market Size by Country
- 8.3.3 U.S. Market Overview
- 8.3.4 Canada Market Overview
- 8.3.5 Mexico Market Overview
- 8.4 Europe
- 8.4.1 Europe mRNA Vaccines for Infectious Diseases Sales by Country
- 8.4.2 Europe mRNA Vaccines for Infectious Diseases Market Size by Country
- 8.4.3 Germany Market Overview
- 8.4.4 France Market Overview
- 8.4.5 U.K. Market Overview
- 8.4.6 Italy Market Overview
- 8.4.7 Spain Market Overview
- 8.5 Asia Pacific
- 8.5.1 Asia Pacific mRNA Vaccines for Infectious Diseases Sales by Region
- 8.5.2 Asia Pacific mRNA Vaccines for Infectious Diseases Market Size by Region
- 8.5.3 China Market Overview
- 8.5.4 Japan Market Overview
- 8.5.5 South Korea Market Overview
- 8.5.6 India Market Overview
- 8.5.7 Southeast Asia Market Overview
- 8.6 South America
- 8.6.1 South America mRNA Vaccines for Infectious Diseases Sales by Country
- 8.6.2 South America mRNA Vaccines for Infectious Diseases Market Size by Country
- 8.6.3 Brazil Market Overview
- 8.6.4 Argentina Market Overview
- 8.6.5 Columbia Market Overview
- 8.7 Middle East and Africa
- 8.7.1 Middle East and Africa mRNA Vaccines for Infectious Diseases Sales by Region
- 8.7.2 Middle East and Africa mRNA Vaccines for Infectious Diseases Market Size by Region
- 8.7.3 Saudi Arabia Market Overview
- 8.7.4 UAE Market Overview
- 8.7.5 Egypt Market Overview
- 8.7.6 Nigeria Market Overview
- 8.7.7 South Africa Market Overview
- 9 mRNA Vaccines for Infectious Diseases Market Production by Region
- 9.1 Global Production of mRNA Vaccines for Infectious Diseases by Region(2020-2025)
- 9.2 Global mRNA Vaccines for Infectious Diseases Revenue Market Share by Region (2020-2025)
- 9.3 Global mRNA Vaccines for Infectious Diseases Production, Revenue, Price and Gross Margin (2020-2025)
- 9.4 North America mRNA Vaccines for Infectious Diseases Production
- 9.4.1 North America mRNA Vaccines for Infectious Diseases Production Growth Rate (2020-2025)
- 9.4.2 North America mRNA Vaccines for Infectious Diseases Production, Revenue, Price and Gross Margin (2020-2025)
- 9.5 Europe mRNA Vaccines for Infectious Diseases Production
- 9.5.1 Europe mRNA Vaccines for Infectious Diseases Production Growth Rate (2020-2025)
- 9.5.2 Europe mRNA Vaccines for Infectious Diseases Production, Revenue, Price and Gross Margin (2020-2025)
- 9.6 Japan mRNA Vaccines for Infectious Diseases Production (2020-2025)
- 9.6.1 Japan mRNA Vaccines for Infectious Diseases Production Growth Rate (2020-2025)
- 9.6.2 Japan mRNA Vaccines for Infectious Diseases Production, Revenue, Price and Gross Margin (2020-2025)
- 9.7 China mRNA Vaccines for Infectious Diseases Production (2020-2025)
- 9.7.1 China mRNA Vaccines for Infectious Diseases Production Growth Rate (2020-2025)
- 9.7.2 China mRNA Vaccines for Infectious Diseases Production, Revenue, Price and Gross Margin (2020-2025)
- 10 Key Companies Profile
- 10.1 Moderna Therapeutics
- 10.1.1 Moderna Therapeutics Basic Information
- 10.1.2 Moderna Therapeutics mRNA Vaccines for Infectious Diseases Product Overview
- 10.1.3 Moderna Therapeutics mRNA Vaccines for Infectious Diseases Product Market Performance
- 10.1.4 Moderna Therapeutics Business Overview
- 10.1.5 Moderna Therapeutics SWOT Analysis
- 10.1.6 Moderna Therapeutics Recent Developments
- 10.2 CureVac
- 10.2.1 CureVac Basic Information
- 10.2.2 CureVac mRNA Vaccines for Infectious Diseases Product Overview
- 10.2.3 CureVac mRNA Vaccines for Infectious Diseases Product Market Performance
- 10.2.4 CureVac Business Overview
- 10.2.5 CureVac SWOT Analysis
- 10.2.6 CureVac Recent Developments
- 10.3 Translate Bio
- 10.3.1 Translate Bio Basic Information
- 10.3.2 Translate Bio mRNA Vaccines for Infectious Diseases Product Overview
- 10.3.3 Translate Bio mRNA Vaccines for Infectious Diseases Product Market Performance
- 10.3.4 Translate Bio Business Overview
- 10.3.5 Translate Bio SWOT Analysis
- 10.3.6 Translate Bio Recent Developments
- 10.4 BioNTech
- 10.4.1 BioNTech Basic Information
- 10.4.2 BioNTech mRNA Vaccines for Infectious Diseases Product Overview
- 10.4.3 BioNTech mRNA Vaccines for Infectious Diseases Product Market Performance
- 10.4.4 BioNTech Business Overview
- 10.4.5 BioNTech Recent Developments
- 10.5 Sangamo Therapeutics
- 10.5.1 Sangamo Therapeutics Basic Information
- 10.5.2 Sangamo Therapeutics mRNA Vaccines for Infectious Diseases Product Overview
- 10.5.3 Sangamo Therapeutics mRNA Vaccines for Infectious Diseases Product Market Performance
- 10.5.4 Sangamo Therapeutics Business Overview
- 10.5.5 Sangamo Therapeutics Recent Developments
- 10.6 Argos Therapeutics
- 10.6.1 Argos Therapeutics Basic Information
- 10.6.2 Argos Therapeutics mRNA Vaccines for Infectious Diseases Product Overview
- 10.6.3 Argos Therapeutics mRNA Vaccines for Infectious Diseases Product Market Performance
- 10.6.4 Argos Therapeutics Business Overview
- 10.6.5 Argos Therapeutics Recent Developments
- 10.7 In-Cell-Art
- 10.7.1 In-Cell-Art Basic Information
- 10.7.2 In-Cell-Art mRNA Vaccines for Infectious Diseases Product Overview
- 10.7.3 In-Cell-Art mRNA Vaccines for Infectious Diseases Product Market Performance
- 10.7.4 In-Cell-Art Business Overview
- 10.7.5 In-Cell-Art Recent Developments
- 10.8 eTheRNA
- 10.8.1 eTheRNA Basic Information
- 10.8.2 eTheRNA mRNA Vaccines for Infectious Diseases Product Overview
- 10.8.3 eTheRNA mRNA Vaccines for Infectious Diseases Product Market Performance
- 10.8.4 eTheRNA Business Overview
- 10.8.5 eTheRNA Recent Developments
- 10.9 Ethris
- 10.9.1 Ethris Basic Information
- 10.9.2 Ethris mRNA Vaccines for Infectious Diseases Product Overview
- 10.9.3 Ethris mRNA Vaccines for Infectious Diseases Product Market Performance
- 10.9.4 Ethris Business Overview
- 10.9.5 Ethris Recent Developments
- 10.10 Tiba Biotechnology
- 10.10.1 Tiba Biotechnology Basic Information
- 10.10.2 Tiba Biotechnology mRNA Vaccines for Infectious Diseases Product Overview
- 10.10.3 Tiba Biotechnology mRNA Vaccines for Infectious Diseases Product Market Performance
- 10.10.4 Tiba Biotechnology Business Overview
- 10.10.5 Tiba Biotechnology Recent Developments
- 11 mRNA Vaccines for Infectious Diseases Market Forecast by Region
- 11.1 Global mRNA Vaccines for Infectious Diseases Market Size Forecast
- 11.2 Global mRNA Vaccines for Infectious Diseases Market Forecast by Region
- 11.2.1 North America Market Size Forecast by Country
- 11.2.2 Europe mRNA Vaccines for Infectious Diseases Market Size Forecast by Country
- 11.2.3 Asia Pacific mRNA Vaccines for Infectious Diseases Market Size Forecast by Region
- 11.2.4 South America mRNA Vaccines for Infectious Diseases Market Size Forecast by Country
- 11.2.5 Middle East and Africa Forecasted Sales of mRNA Vaccines for Infectious Diseases by Country
- 12 Forecast Market by Type and by Application (2026-2033)
- 12.1 Global mRNA Vaccines for Infectious Diseases Market Forecast by Type (2026-2033)
- 12.1.1 Global Forecasted Sales of mRNA Vaccines for Infectious Diseases by Type (2026-2033)
- 12.1.2 Global mRNA Vaccines for Infectious Diseases Market Size Forecast by Type (2026-2033)
- 12.1.3 Global Forecasted Price of mRNA Vaccines for Infectious Diseases by Type (2026-2033)
- 12.2 Global mRNA Vaccines for Infectious Diseases Market Forecast by Application (2026-2033)
- 12.2.1 Global mRNA Vaccines for Infectious Diseases Sales (K MT) Forecast by Application
- 12.2.2 Global mRNA Vaccines for Infectious Diseases Market Size (M USD) Forecast by Application (2026-2033)
- 13 Conclusion and Key Findings
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
